As of June 2026 Royalty Pharma has a market cap of HK$244.86 Billion. This makes Royalty Pharma the world's 800th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Jun 16th, 2026 the market cap of Royalty Pharma was reported to be: